http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111892536-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2019-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111892536-B |
| titleOfInvention | Substituted quinoline carboxamides and their use |
| abstract | The invention belongs to the technical field of pharmaceutical chemistry, and relates to a substituted quinoline formamide compound and application thereof. The substituted quinoline carboxamide compound has excellent in-vitro inhibitory activity on FGFR-4, VEGFR-2 and PDGFR-beta kinases, can be used as a micromolecular tyrosine kinase inhibitor, has the effects of inhibiting cell proliferation and angiogenesis, has good antitumor activity, and has good effect on treating mammal (including human) tumor diseases. |
| priorityDate | 2019-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.